Recruiting Depression Studies in Oceanside
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder
X-NOVA2 is a Phase 3, multicenter, randomized, double-blind, placebo-controlled study to evaluate the clinical efficacy, safety, and tolerability of azetukalner as a monotherapy in adult participants ...
A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms
This is a randomized, double-blind, active-controlled, multi-center study to evaluate the efficacy of AXS-05, compared to bupropion, in preventing the relapse of depressive symptoms in subjects with m...
"A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder"
The purpose of this study is to examine the efficacy, safety, and tolerability of CYB003 compared to matching placebo as adjunctive treatment in participants with MDD....
ALTO-100 in Bipolar Disorder With Depression (BD-D)
The purpose of this study is to assess antidepressant efficacy differences between ALTO-100 and placebo during the Double-Blind period in patients with bipolar disorder I or II with current major depr...
Study to Evaluate Efficacy and Safety of Ropanicant in MDD Patients
The primary objective is to evaluate the efficacy of Ropanicant at two different dosage levels compared to placebo in patients with Major Depressive Disorder (MDD)....
PD, PK, and Safety of ALTO-203 in Patients With MDD
The goal of this clinical trial is to determine the pharmacodynamic effects of ALTO-203 in patients with MDD in a randomized, placebo-controlled, single-dose crossover treatment period. Additionally, ...
About Depression Clinical Trials in Oceanside
Depression (major depressive disorder) is a common and serious mood disorder that negatively affects how you feel, think, and handle daily activities. It affects over 280 million people globally. Treatment includes psychotherapy, antidepressant medications, and brain stimulation therapies.
There are currently 6 depression clinical trials recruiting participants in Oceanside, CALIFORNIA. These studies are seeking a combined 1,475 participants. Research is being sponsored by Xenon Pharmaceuticals Inc., Axsome Therapeutics, Inc., Cybin IRL Limited and 2 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.
Depression Clinical Trials in Oceanside — FAQ
Are there depression clinical trials in Oceanside?
Yes, there are 6 depression clinical trials currently recruiting in Oceanside, CALIFORNIA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Oceanside?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Oceanside research site will contact you about next steps.
Are clinical trials in Oceanside free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Oceanside studies also compensate for your time and travel.
What depression treatments are being tested?
The 6 active trials in Oceanside are testing new therapies including novel drugs, biologics, and treatment approaches for depression.
Data updated March 2, 2026 from ClinicalTrials.gov